The objective of this study was to explore the possible prognostic and predictive role of topoisomerase II alpha (TopIIα) expression level in postoperative NSCLC patients who received adjuvant chemotherapy. The gene discussed is TOP2A; the disease is non-small cell lung carcinoma.